SBIO

ALPS Medical Breakthroughs
LAST TRADECHANGE (%)VOLUME
$26.30-- (--)54.54K
4:00:00 p.m. (ET) 02/27/2017
BID SIZEBID ($)ASK ($)ASK SIZE
20025.7626.46100

Overall Rating

N/A

N/A
as of 02/27/17

Rating Details

N/A
N/A
N/A
Segment Average
  • Overview
  • Efficiency
  • Tradability
  • Fit

SBIO Fund Description

The ALPS Medical Breakthroughs ETF tracks the Poliwogg Medical Breakthroughs Index, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.

SBIO FactSet Analytics Insight

The ALPS Medical Breakthroughs ETF (SBIO)high-risk and high-reward targets biotech companies with drugs in Phase II and Phase III of FDA clinical trials. The fund limits itself to US-listed companies with market caps between $200M and $5B. SBIO also has screens for liquidity and sustainability of its constituents. (Sustainability in this context means that constituent firms have enough cash on hand to last 2 years.) Given the low historical success rates in clinical trials, the fund is a high-risk and high-reward bet on a small subset of biotech companies. If you’re looking for broad biotech exposure, you won’t find it in SBIO; however, you will find a new competing fund with a similar thesis in BBC. Check back in 6 months for more detailed analysis.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

SBIO Top 10 Countries

SBIO Top 10 Sectors

SBIO Top 10 Holdings

This chart is unavailable

SBIO Summary Data

12/31/14
Open-Ended Fund
0.50%
$101.78 M
$967.13 K
0.34%

SBIO Portfolio Data

$2.26 B
-16.69
3.28
0%
12/20/17
83

SBIO Index Data

Poliwogg Medical Breakthroughs Index
Market Cap
Fundamental
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to SBIO

N/A
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

SBIO Portfolio Management

0.50%
--
--
--

SBIO Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

SBIO Fund Structure

Open-Ended Fund
No
Yes
0% / 100%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
10026.56
20026.48
10026.46
BIDS20025.76
10025.72
10025.06
10024.60
30024.41
LAST 10 TRADES
TIMEPRICESHARES
------
------
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 09:32:13
Average Spread
Premium/Discount
Volume

SBIO FactSet Analytics Block Liquidity

As of 02/27/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of SBIO. SBIO is rated a 5 out of 5.

SBIO Tradability

40,633
$967.13 K
35,623
$828.9 K
0.34%
$0.08
-0.03%
0.91% / -0.25%
None
100.00%
50,000
0.71
0.04%
0.20%
491
$25.10
5

SBIO Performance Statistics

0.80
1.38
1.31
1.39
1.21%
Thomson Reuters US Biotechnology & Medical Research